SAQA All qualifications and part qualifications registered on the National Qualifications Framework are public property. Thus the only payment that can be made for them is for service and reproduction. It is illegal to sell this material for profit. If the material is reproduced or quoted, the South African Qualifications Authority (SAQA) should be acknowledged as the source.
SOUTH AFRICAN QUALIFICATIONS AUTHORITY 
REGISTERED UNIT STANDARD THAT HAS PASSED THE END DATE: 

Act in accordance with ethical and legal codes of pharmaceutical representation and the laws of the country 
SAQA US ID UNIT STANDARD TITLE
259362  Act in accordance with ethical and legal codes of pharmaceutical representation and the laws of the country 
ORIGINATOR
SGB Pharmacy 
PRIMARY OR DELEGATED QUALITY ASSURANCE FUNCTIONARY
-  
FIELD SUBFIELD
Field 09 - Health Sciences and Social Services Curative Health 
ABET BAND UNIT STANDARD TYPE PRE-2009 NQF LEVEL NQF LEVEL CREDITS
Undefined  Regular  Level 5  Level TBA: Pre-2009 was L5  6 
REGISTRATION STATUS REGISTRATION START DATE REGISTRATION END DATE SAQA DECISION NUMBER
Passed the End Date -
Status was "Reregistered" 		 2018-07-01  2023-06-30  SAQA 06120/18 
LAST DATE FOR ENROLMENT LAST DATE FOR ACHIEVEMENT
2024-06-30   2027-06-30  

In all of the tables in this document, both the pre-2009 NQF Level and the NQF Level is shown. In the text (purpose statements, qualification rules, etc), any references to NQF Levels are to the pre-2009 levels unless specifically stated otherwise.  

This unit standard does not replace any other unit standard and is not replaced by any other unit standard. 

PURPOSE OF THE UNIT STANDARD 
This unit standard is for learners who are entering the pharmaceutical sales environment. 'Pharmaceutical' includes medicines, medical products, medical devices, scheduled substances, veterinary medicines, products and devices, in accordance with the relevant current legislation. Learners will be able to apply ethical and legal codes in their day-to-day activities.

The learner credited with this unit standard will be able to:
  • Demonstrate ethical behaviour.
  • Maintain customer confidentiality.
  • Develop self as a professional person.
  • Act in an advocacy role to protect customer rights.

    'Customer' refers to the recipient of the service, whether human or animal.
    All activities are carried out according to the current relevant codes of practice. 
    		•

    LEARNING ASSUMED TO BE IN PLACE AND RECOGNITION OF PRIOR LEARNING 
  • Communication at NQF Level 4 or equivalent.

    Recognition of Prior Learning:

    A learner may be accredited against this unit standard in terms of recognition of prior learning, based on accreditable evidence of competence in all the required specific outcomes of this, and all the unit standards specified under the heading Learning Assumed to be in Place; and in accordance with the requirements of the relevant ETQA or ETQA that has a Memorandum of Understanding in place with the relevant ETQA. 
    		•

    UNIT STANDARD RANGE 
    N/A 

    Specific Outcomes and Assessment Criteria: 

    SPECIFIC OUTCOME 1 
    Demonstrate ethical behaviour. 

    ASSESSMENT CRITERIA     

    ASSESSMENT CRITERION 1 
    Own personal position is demonstrated in response to ethical dilemmas. 

    ASSESSMENT CRITERION 2 
    All actions display compliance with the pharmaceutical marketing code. 

    ASSESSMENT CRITERION 3 
    The values of the professional ethical value system are applied in all interactions with customers. 

    ASSESSMENT CRITERION 4 
    Situations outside scope of competence are referred to an appropriate source. 

    ASSESSMENT CRITERION 5 
    Information is delivered accurately and in a manner that preserves and protects client dignity and rights. 

    SPECIFIC OUTCOME 2 
    Develop self as a professional person. 

    ASSESSMENT CRITERIA     

    ASSESSMENT CRITERION 1 
    Responsibility and accountability for own behaviour is described in accordance with, professional codes of practice. 

    ASSESSMENT CRITERION 2 
    Opportunities for professional development are identified and assessed to meet personal and professional development goals. 

    ASSESSMENT CRITERION 3 
    Recent developments in the field are identified and applied in day to day activities. 
    ASSESSMENT CRITERION RANGE 
    Identification opportunities include, but are not limited to:
  • Structured reading, journals, discussion groups, conferences, employer opportunities, case presentations, information on new medications.
     
    		•

    ASSESSMENT CRITERION 4 
    The marketing codes of conduct are complied with in day-to-day activities. 

    SPECIFIC OUTCOME 3 
    Act in an advocacy role to protect customer rights. 

    ASSESSMENT CRITERIA     

    ASSESSMENT CRITERION 1 
    Own actions consistently protect and promote customer rights. 

    ASSESSMENT CRITERION 2 
    Conflicting loyalties are identified and resolved in terms of professional ethical values and codes of ethics. 

    ASSESSMENT CRITERION 3 
    When own principles conflict with professional requirements the matter is referred timeously and appropriately. 

    SPECIFIC OUTCOME 4 
    Maintain customer confidentiality. 

    ASSESSMENT CRITERIA     

    ASSESSMENT CRITERION 1 
    Discussions with regard to any patient's condition is limited to relevant parties, with the consent of the patient or guardian, as applicable. 

    ASSESSMENT CRITERION 2 
    The consequences of breaking confidentiality are explained with reference to disciplinary policies and bodies. 

    ASSESSMENT CRITERION 3 
    Own practice is conducted in a manner that supports and promotes the confidentiality of client information. 


    UNIT STANDARD ACCREDITATION AND MODERATION OPTIONS 
  • Anyone assessing the learner against this unit standard must be accredited as an assessor with the relevant ETQA or ETQA that has a Memorandum of Understanding in place with the relevant ETQA.
  • Any provider offering learning that will enable achievement of this unit standard must be registered with the relevant ETQA or ETQA that has a Memorandum of Understanding in place with the relevant ETQA.
  • The moderation of this standard will be conducted according to the requirements of relevant ETQA or ETQA that has a Memorandum of Understanding in place with the relevant ETQA. 
    		•

    UNIT STANDARD ESSENTIAL EMBEDDED KNOWLEDGE 
  • Applicable legislation and ethical codes of conduct as they apply to the pharmaceutical industry.
  • Models of ethical decision making. 
    		•

    UNIT STANDARD DEVELOPMENTAL OUTCOME 
    N/A 

    UNIT STANDARD LINKAGES 
    N/A 


    Critical Cross-field Outcomes (CCFO): 

    UNIT STANDARD CCFO IDENTIFYING 
    Identifying and solving problems and making decisions using critical and creative thinking are demonstrated in behaving ethically and acting in an advocacy role. 

    UNIT STANDARD CCFO WORKING 
    Working effectively with others as members of a team, group, organisation or community is demonstrated in behaving ethically and acting in an advocacy role. 

    UNIT STANDARD CCFO ORGANISING 
    Organising and managing themselves and their activities responsibly and effectively are demonstrated in behaving ethically and acting in an advocacy role. 

    UNIT STANDARD CCFO COMMUNICATING 
    Communicating effectively is demonstrated in behaving ethically and acting in an advocacy role. 

    UNIT STANDARD ASSESSOR CRITERIA 
    N/A 

    REREGISTRATION HISTORY 
    As per the SAQA Board decision/s at that time, this unit standard was Reregistered in 2012; 2015. 

    UNIT STANDARD NOTES 
    Integrated Assessment:

    Assessment will be based on:
  • Formal classroom training.
  • Written assessment.
  • Portfolio of evidence demonstrating understanding.
  • Demonstrate knowledge in sales situation.

    The learner should demonstrate the ability to explain concepts in a clear and understandable manner and in language that is appropriate for the target audience.

    Credit Justification:
  • Classroom Learning, 16 hours, 1.6 credits
  • Written Assessment, 2 hours, 0.2 credits
  • Portfolio of Evidence, 20 hours, 2 credits
  • Self directed / Experiential, 22 hours, 2.2 credits 
    		•

    QUALIFICATIONS UTILISING THIS UNIT STANDARD: 
      ID QUALIFICATION TITLE PRE-2009 NQF LEVEL NQF LEVEL STATUS END DATE PRIMARY OR DELEGATED QA FUNCTIONARY
    Fundamental  63969   National Certificate: Pharmaceutical Sales Representation  Level 5  Level TBA: Pre-2009 was L5  Passed the End Date -
    Status was "Reregistered"     		 2023-06-30  CHIETA 


    PROVIDERS CURRENTLY ACCREDITED TO OFFER THIS UNIT STANDARD: 
    This information shows the current accreditations (i.e. those not past their accreditation end dates), and is the most complete record available to SAQA as of today. Some Primary or Delegated Quality Assurance Functionaries have a lag in their recording systems for provider accreditation, in turn leading to a lag in notifying SAQA of all the providers that they have accredited to offer qualifications and unit standards, as well as any extensions to accreditation end dates. The relevant Primary or Delegated Quality Assurance Functionary should be notified if a record appears to be missing from here.
     
    NONE 


    All qualifications and part qualifications registered on the National Qualifications Framework are public property. Thus the only payment that can be made for them is for service and reproduction. It is illegal to sell this material for profit. If the material is reproduced or quoted, the South African Qualifications Authority (SAQA) should be acknowledged as the source.